The genius of a good product designer is the ability to create an experience that delights the end user. The designer rarely invents the components; he or she makes them noticed. Smartphones, microfluidics, low-power devices, 1-way valves, optical sensing, multiplexed assays, frequency-shift keying, and lyophilization are not new technologies. A device that successfully orchestrates these instruments to screen for HIV and active syphilis in 15 min, with validation in the field, is new-and important. Aaron Wheeler, Professor of Chemistry at the University of Toronto and an associate editor of Laboratory On a Chip, would know.
"We all should acknowledge the popular overused motivation to try to make things small, inexpensive, and point-ofcare," he says. Whereas something like 50% of microfluidics papers that come into Laboratory On a Chip talk about being point-of-care, they are "far from it," Wheeler explains, and this leads to hype rather than real progress. That is, "except for shining bright lights like Sam Sia. Everyone else talks about this, but Sam delivers."
In a multiyear engineering effort, Sia, Associate Professor of Biomedical Engineering at Columbia University, developed and rigorously tested a novel smartphone diagnostic that he spoke about in earlier e-mail correspondence.
What Is This Innovation?
Although it might sound more like the latest trend in smartphone accessories than a sophisticated diagnostic tool, Sia's innovation is most easily described as a "smartphone dongle" (1 ) . But such a moniker might undersell the product. What it is, actually, is a diagnostic tool that scans the patient's blood for HIV and syphilis (Fig.  1) . The dongle itself is a disposable plastic cartridge with preloaded reagents; it is "small and light enough to fit in one hand," write the study authors. Add a fingerprick of whole blood to the dongle, and it concurrently analyzes for 3 separate antibodies: 1 for HIV and 2 for syphilis.
In the article's abstract, Sia's team lays it out: "This low-cost dongle replicates all mechanical, optical, and electronic functions of a laboratory-based enzyme-linked immunosorbent assay [ELISA] without requiring any stored energy." It does this by drawing all its power from the smartphone's audio jack, the port at which the dongle is attached to the phone.
It is this feature, the use of the audio jack, that most impresses Wheeler.
"Now, an audio engineer might say, this is obvious, why isn't everyone doing it," says Wheeler, in regard to using the audio jack as a power resource. "And they're probably right."
What makes Sam Sia different, says Wheeler, is that even though he is not an audio engineer, "he sees something from a different field and he thinks, could that work here?" More often than not, says Wheeler, Sia is right, and it does. Although you can buy an audio jack to USB adaptor cable from Amazon.com, the real innovation is the design of the dongle to consume only 1.6 mW power over 15 min (for reference, a typical laser pointer uses 1-5mW) (2 ) .
A further innovation is the inclusion of an antibody to treponemal syphilis and nontreponemal syphilis, as the latter is present only in active disease.
How Does It Work?
The test requires 1 L whole blood to be mixed with 9 L of a diluent. Two microliters of the mixture is added to the disposable cassette, after which the antibody holder is attached to the cassette. The cassette is then inserted in the dongle and a bulb is manually depressed to cleverly generate negative pressure that moves blood and reagents in the cassette without the need for a powered pump (Fig.  2) . A vacuum is created as the bulb is connected at 1 end to the assay cassette outlet and at the other end to a 1-way valve. Upon depression, air exits through the 1-way valve and a spring reexpands the bulb to create the driving negative pressure. After starting the vacuum, a button on the smartphone app is tapped to "start assay."
The cassette has 5 detection zones with surface-laid proteins for detection of HIV (gp41, gp36, O immunodominant region), treponemal syphilis (17-kD recombinant outer membrane protein TpN17), nontreponemal syphilis (synthetic cardiolipin), a positive control (rabbit antigoat IgG), and a negative control (blocking agent). Blood flows through the cassette first, and antibodies present in blood bind to the surface capture proteins. Gold-labeled antihuman IgG and IgM flow next, followed by washes to label any bound antibody. This is the completion of phase 1 and lasts 5 min. The app instructs the user to close a venting port to start phase 2, in which silver reagents mix to amplify the signal.
And now for the innovation that has Wheeler impressed. Power for absorbance measurements is transmitted to the dongle through the audio jack of the phone. A 19-kHz audio signal forms a stable DC 3 V to power the light-emitting diodes that transmit light, whose absorbance (of silver enhancement) in a zone is measured by a photodiode as evidence of bound substrate. A low-power microcontroller converts the analog absorbance to digital and uses frequency-shift keying to represent the digital signal as an audio wave that can be transmitted through the audio jack and decoded by the phone. The ultimate result can be absorbance units or, based on cutoff values, positive or negative.
The entire assay takes 15 min to run compared with a minimum of 1 h for the more traditional ELISA test. Sia reports it to be cheaper as well: $1.44 for all reagents and materials compared to $8.50 for 3 individual tests for HIV and syphilis.
Sia tested his device with about 100 patients at 3 health centers in Kigali, Rwanda. He used laboratorybased HIV ELISA, Treponema pallidum hemagglutination, and rapid plasma reagin as gold standard tests. His test showed a sensitivity of 100% and specificity of 87% for HIV antibodies, sensitivity 92% and specificity 92% for treponemal antibodies, and sensitivity 100% and specificity 79% for nontreponemal antibodies. The area under the ROC curve was 0.96 for HIV, 0.90 for treponemal syphilis, and 0.92 for nontreponemal syphilis.
Does It Hold Up?
All in all, you would be hard-pressed to find someone who is not impressed by this dongle: a quick Google search shows it has caught the attention of media outlets as varied as the Washington Post, CBS News, and Cosmopolitan magazine, plus other outlets all over the world.
With a device as heralded as this, Wheeler says that next steps in product development are often more sociological than technological. He tells the story of a friend (not Sia) who created a diagnostic tool for a low-resource setting, only to take the tool to the community-and no one wanted to use it. What they really wanted was not a diagnostic tool that could be used in their village, even in their very own homes, but a truck, so they could drive to the hospital and be tested anonymously. Says Wheeler, "that's humbling, right?" His point is that when creating these point-ofcare tools, the real world is complicated-it's not just about how well the tool works, but whether, "if 1 billion were magically made available," anyone would use them.
He believes that Sia has taken first steps to tap into the sociological mindset: as part of Sia's Rwandan field test, patients and healthcare workers participated in a survey (done by a third-party interviewer fluent in both English and the local Kinyarwanda). Ninety-seven percent of patients said they would recommend the dongle to others, whereas the healthcare workers appreciated "the lack of user interpretation to read the result or external power to operate."
In an e-mail, Sia said that user experience is important to him. "Many pieces are needed to build a fully functioning 'sample to result' device that is easy to use by the user," he writes. "In fact, users expect the device to work like smartphone app. The only way this would be possible is if usability factors are designed into the device as well as analytical performance." And that's just the thing, says Wheeler: whereas often those other point-of-care designs that float across his desk have either usability or performance, with this dongle, Sia has both.
"In my field, we're so interested in new, and small, and fancy," says Wheeler. "Yet, it doesn't always translate to 'works well' for the healthcare worker, or the patient." But, he says, Sia is willing to make something a little bit simpler, "a little less sexy," to make a thing that works.
"He is a pioneer." 
